Design Therapeutics, Inc.
DSGN
$5.41
$0.214.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.08M | -17.72M | -13.65M | -13.04M | -11.79M |
| Total Depreciation and Amortization | 152.00K | 159.00K | 149.00K | 153.00K | 151.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.50M | 2.48M | 2.03M | 1.66M | 1.73M |
| Change in Net Operating Assets | 994.00K | -1.71M | 1.61M | 1.68M | -1.35M |
| Cash from Operations | -14.44M | -16.79M | -9.86M | -9.55M | -11.26M |
| Capital Expenditure | -87.00K | -72.00K | 0.00 | 16.00K | -161.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.20M | 7.94M | 1.83M | -5.84M | 27.49M |
| Cash from Investing | 20.12M | 7.87M | 1.83M | -5.83M | 27.33M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 361.00K | 23.00K | 263.00K | 1.00K | 229.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 361.00K | 23.00K | 263.00K | 1.00K | 229.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.04M | -8.90M | -7.77M | -15.37M | 16.30M |